Polarean Imaging plc
LSE: POLX.L0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- London Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Christopher Richard Von Jako
- Employees
- 29
- Headquarters
- London, United States
- IPO year
- 2018
- Market cap
- £965.6K
- Website
- https://polarean.com
Loading POLX…
Loading profile data…Frequently asked questions about POLX
What does Polarean Imaging plc (POLX.L) do?
Polarean Imaging plc operates as a medical drug-device combination company serving the medical imaging market in the United States, Canada, Germany, and the United Kingdom. The company engages in the development and commercialization of gas polarizer devices and ancillary instruments. It develops equipment that enables existing magnetic resonanc...
Where does POLX.L trade?
Polarean Imaging plc (POLX.L) trades on the London Stock Exchange.
What sector is POLX.L in?
Polarean Imaging plc (POLX.L) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Polarean Imaging plc?
Christopher Richard Von Jako is the chief executive officer of Polarean Imaging plc (POLX.L).
Where is Polarean Imaging plc headquartered?
Polarean Imaging plc is headquartered in United States.
Does POLX.L pay a dividend?
Polarean Imaging plc (POLX.L) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did POLX.L go public?
Polarean Imaging plc (POLX.L) completed its initial public offering in 2018.